| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net income | 7,218 | 4,742 |
| Depreciation of property, plant and equipment | 2,719 | 1,404 |
| Amortization of intangible assets | 9,087 | 4,553 |
| Stock-based compensation expense | 7,693 | 3,881 |
| Gain on extinguishment of convertible notes | 0 | 0 |
| Amortization of step-up in inventory basis | 0 | 0 |
| Foreign currency adjustments | 6,081 | 5,986 |
| Other | -2,878 | -1,250 |
| Accounts receivable, net | -1,740 | -3,436 |
| Inventories | 4,056 | 3,290 |
| Prepaid expenses and other assets | 823 | 2,436 |
| Accounts payable | -997 | 212 |
| Accrued liabilities and taxes payable | -8,505 | -5,928 |
| Unearned revenues | -758 | 55 |
| Net cash provided by operating activities | 10,115 | 1,893 |
| Purchases of property, plant and equipment | 2,101 | 1,009 |
| Net cash (used in) investing activities | -2,101 | -1,009 |
| Proceeds from debt borrowings | 107,500 | 10,500 |
| Repurchase and settlement of convertible note debt | 97,500 | 0 |
| Other debt principal repayments | 13,375 | 7,438 |
| Gke acquisition-related holdback payment-Gke Acquisition | 9,555 | 9,555 |
| Dividends paid | 1,755 | 873 |
| Other financing, net | -1,625 | -1,061 |
| Net cash (used in) financing activities | -16,310 | -8,427 |
| Effect of exchange rate changes on cash and cash equivalents | 1,397 | 1,501 |
| Net (decrease) in cash and cash equivalents | -6,899 | -6,042 |
| Cash and cash equivalents at beginning of period | 27,321 | - |
| Cash and cash equivalents at end of period | 20,422 | - |
MESA LABORATORIES INC CO (MLAB)
MESA LABORATORIES INC CO (MLAB)